Numida meleagris isolate 19003 breed g44 Domestic line chromosome 19, NumMel1.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Numididae; Numida.
REFSEQ INFORMATION: The reference sequence is identical to\nCM007832.2.\nAssembly name: NumMel1.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the INRA on 2017/06/01. The\noriginal whole-genome shotgun project has the accession\nMTSP00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: INRA\nAssembly Date :: JUL-2013\nAssembly Method :: AllPaths v. July-2013\nAssembly Name :: NumMel1.0\nReference-guided Assembly :: Gallus_gallus-5.0 (GCF_000002315.4)\nGenome Coverage :: 100.0x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Version :: Numida meleagris Annotation Release\n 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 7.4\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC110408269, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC110408269, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
immunoglobulin superfamily member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
L3MBTL1, histone methyl-lysine binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
L3MBTL1, histone methyl-lysine binding protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
L3MBTL1, histone methyl-lysine binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
L3MBTL1, histone methyl-lysine binding protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
lethal(3)malignant brain tumor-like protein 1 isoform X2
lethal(3)malignant brain tumor-like protein 1 isoform X1
lethal(3)malignant brain tumor-like protein 1 isoform X3
serine and arginine rich splicing factor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
serine and arginine rich splicing factor 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
serine/arginine-rich splicing factor 6 isoform X2
serine/arginine-rich splicing factor 6 isoform X1
erythrocyte membrane protein band 4.1 like 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
erythrocyte membrane protein band 4.1 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X5
erythrocyte membrane protein band 4.1 like 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
DLG associated protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DLG associated protein 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DLG associated protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DLG associated protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
disks large-associated protein 4 isoform X1
disks large-associated protein 4 isoform X2
disks large-associated protein 4 isoform X3
disks large-associated protein 4 isoform X4
TGFB induced factor homeobox 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
TGFB induced factor homeobox 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
chromosome 19 C20orf24 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
chromosome 19 C20orf24 homolog, transcript variant X1
chromosome 19 C20orf24 homolog, transcript variant X3
chromosome 19 C20orf24 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized protein C20orf24 homolog isoform X2
uncharacterized protein C20orf24 homolog isoform X4
uncharacterized protein C20orf24 homolog isoform X1
uncharacterized protein C20orf24 homolog isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
nuclear receptor coactivator 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
nuclear receptor coactivator 6, transcript variant X1
nuclear receptor coactivator 6 isoform X1
nuclear receptor coactivator 6 isoform X2
tumor protein p53 inducible nuclear protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
tumor protein p53 inducible nuclear protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 2 isoform X2
tumor protein p53-inducible nuclear protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class U
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class U protein
TBC/LysM-associated domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TLD domain-containing protein 2 isoform X2
TBC/LysM-associated domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TLD domain-containing protein 2 isoform X1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X2
deoxynucleoside triphosphate triphosphohydrolase SAMHD1 isoform X1
deoxynucleoside triphosphate triphosphohydrolase SAMHD1 isoform X3
deoxynucleoside triphosphate triphosphohydrolase SAMHD1 isoform X2
deoxynucleoside triphosphate triphosphohydrolase SAMHD1 isoform X4
RB transcriptional corepressor like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
RB transcriptional corepressor like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
RB transcriptional corepressor like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
RB transcriptional corepressor like 1, transcript variant X4
retinoblastoma-like protein 1 isoform X1
retinoblastoma-like protein 1 isoform X3
retinoblastoma-like protein 1 isoform X2
retinoblastoma-like protein 1 isoform X4
chromodomain helicase DNA binding protein 6, transcript variant X7
chromodomain helicase DNA binding protein 6, transcript variant X5
chromodomain helicase DNA binding protein 6, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X1
chromodomain helicase DNA binding protein 6, transcript variant X2
chromodomain helicase DNA binding protein 6, transcript variant X6
chromodomain-helicase-DNA-binding protein 6 isoform X5
chromodomain-helicase-DNA-binding protein 6 isoform X8
chromodomain-helicase-DNA-binding protein 6 isoform X4
chromodomain-helicase-DNA-binding protein 6 isoform X3
chromodomain-helicase-DNA-binding protein 6 isoform X1
chromodomain-helicase-DNA-binding protein 6 isoform X2
chromodomain-helicase-DNA-binding protein 6 isoform X6
chromodomain-helicase-DNA-binding protein 6 isoform X7
Ral GTPase activating protein non-catalytic beta subunit, transcript variant X4
Ral GTPase activating protein non-catalytic beta subunit, transcript variant X3
Ral GTPase activating protein non-catalytic beta subunit, transcript variant X1
Ral GTPase activating protein non-catalytic beta subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ral GTPase-activating protein subunit beta isoform X2
ral GTPase-activating protein subunit beta isoform X1
NDRG family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NDRG family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Src like adaptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Src like adaptor 2, transcript variant X2
PHD finger protein 20, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
PHD finger protein 20, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
PHD finger protein 20, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
PHD finger protein 20, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
PHD finger protein 20, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
PHD finger protein 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
PHD finger protein 20, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PHD finger protein 20, transcript variant X4
PHD finger protein 20, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized LOC110408414, transcript variant X1
uncharacterized LOC110408414, transcript variant X2
rho GTPase-activating protein 39-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
rho GTPase-activating protein 39-like, transcript variant X3
rho GTPase-activating protein 39-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
rho GTPase-activating protein 39-like isoform X1
rho GTPase-activating protein 39-like isoform X3
rho GTPase-activating protein 39-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
RNA binding motif protein 39, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
RNA binding motif protein 39, transcript variant X7
RNA binding motif protein 39, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
RNA binding motif protein 39, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
RNA binding motif protein 39, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
RNA binding motif protein 39, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
RNA binding motif protein 39, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
RNA binding motif protein 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
RNA binding motif protein 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01029103.1
similar to RNA sequence (same species):INSD:GBYG01029106.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 524 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 328 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X1
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X3
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X1
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X5
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X2
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X3
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1-like isoform X4
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like, transcript variant X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like isoform X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like isoform X3
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
endoplasmic reticulum-Golgi intermediate compartment protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
centrosomal protein 250, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
centrosomal protein 250, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
centrosomal protein 250, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
centrosomal protein 250, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
centrosomal protein 250, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
centrosomal protein 250, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
centrosomal protein 250, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
centrosomal protein 250, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
centrosome-associated protein CEP250 isoform X2
centrosome-associated protein CEP250 isoform X3
centrosome-associated protein CEP250 isoform X5
centrosome-associated protein CEP250 isoform X4
centrosome-associated protein CEP250 isoform X1
centrosome-associated protein CEP250 isoform X7
centrosome-associated protein CEP250 isoform X8
centrosomal protein 250, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
centrosomal protein 250, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
centrosome-associated protein CEP250 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X1
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X4
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X2
family with sequence similarity 83 member C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 6
similar to RNA sequence (same species):INSD:GBYG01014277.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 101 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 99 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
itchy E3 ubiquitin protein ligase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
E3 ubiquitin-protein ligase Itchy homolog
itchy E3 ubiquitin protein ligase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 2 subunit beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
eukaryotic translation initiation factor 2 subunit 2
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X2
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibrous sheath-interacting protein 2-like, transcript variant X2
fibrous sheath-interacting protein 2-like, transcript variant X1
fibrous sheath-interacting protein 2-like isoform X2
fibrous sheath-interacting protein 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
N-terminal EF-hand calcium binding protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
N-terminal EF-hand calcium binding protein 3, transcript variant X2
N-terminal EF-hand calcium-binding protein 3
CBFA2/RUNX1 translocation partner 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
CBFA2/RUNX1 translocation partner 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CBFA2/RUNX1 translocation partner 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CBFA2/RUNX1 translocation partner 2, transcript variant X5
CBFA2/RUNX1 translocation partner 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X9
TOX high mobility group box family member 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X3
TOX high mobility group box family member 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
TOX high mobility group box family member 2 isoform X7
TOX high mobility group box family member 2 isoform X4
TOX high mobility group box family member 2 isoform X3
TOX high mobility group box family member 2 isoform X8
TOX high mobility group box family member 2 isoform X6
TOX high mobility group box family member 2 isoform X5
TOX high mobility group box family member 2 isoform X2
TOX high mobility group box family member 2 isoform X1
TOX high mobility group box family member 2 isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC110408446, transcript variant X1
uncharacterized LOC110408446, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC110408446, transcript variant X2
uncharacterized protein LOC110408446 isoform X2
uncharacterized protein LOC110408446 isoform X1
ER degradation enhancing alpha-mannosidase like protein 2
ER degradation-enhancing alpha-mannosidase-like protein 2
transient receptor potential cation channel subfamily C member 4 associated protein
short transient receptor potential channel 4-associated protein
myosin heavy chain 7B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
myosin heavy chain 7B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myosin heavy chain 7B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutathione synthetase, transcript variant X1
glutathione synthetase, transcript variant X2
glutathione synthetase, transcript variant X3
acyl-CoA synthetase short-chain family member 2, transcript variant X1
acyl-CoA synthetase short-chain family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
acetyl-coenzyme A synthetase, cytoplasmic isoform X2
acetyl-coenzyme A synthetase, cytoplasmic isoform X1
suppressor of glucose, autophagy associated 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
suppressor of glucose, autophagy associated 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
protein tyrosine phosphatase, receptor type T, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase, receptor type T, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein tyrosine phosphatase, receptor type T, transcript variant X5
protein tyrosine phosphatase, receptor type T, transcript variant X4
protein tyrosine phosphatase, receptor type T, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase, receptor type T, transcript variant X3
protein tyrosine phosphatase, receptor type T, transcript variant X6
protein tyrosine phosphatase, receptor type T, transcript variant X8
receptor-type tyrosine-protein phosphatase T isoform X1
receptor-type tyrosine-protein phosphatase T isoform X2
receptor-type tyrosine-protein phosphatase T isoform X5
receptor-type tyrosine-protein phosphatase T isoform X4
receptor-type tyrosine-protein phosphatase T isoform X9
receptor-type tyrosine-protein phosphatase T isoform X3
receptor-type tyrosine-protein phosphatase T isoform X6
receptor-type tyrosine-protein phosphatase T isoform X8
protein tyrosine phosphatase, receptor type T, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase T isoform X7
uncharacterized LOC110408476, transcript variant X1
uncharacterized LOC110408476, transcript variant X2
uncharacterized LOC110408246, transcript variant X1
uncharacterized LOC110408246, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC110408198, transcript variant X2
uncharacterized LOC110408198, transcript variant X1
MYB proto-oncogene like 2, transcript variant X2
MYB proto-oncogene like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
intraflagellar transport 52, transcript variant X1
intraflagellar transport 52, transcript variant X2
intraflagellar transport protein 52 homolog isoform X2
intraflagellar transport protein 52 homolog isoform X1
SGK2, serine/threonine kinase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SGK2, serine/threonine kinase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SGK2, serine/threonine kinase 2, transcript variant X2
SGK2, serine/threonine kinase 2, transcript variant X4
serine/threonine-protein kinase Sgk2 isoform X3
serine/threonine-protein kinase Sgk2 isoform X1
serine/threonine-protein kinase Sgk2 isoform X2
serine/threonine-protein kinase Sgk2 isoform X4
vesicular inhibitory amino acid transporter
Rho GTPase activating protein 40, transcript variant X4
Rho GTPase activating protein 40, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Rho GTPase activating protein 40, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Rho GTPase activating protein 40, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Rho GTPase activating protein 40, transcript variant X5
Rho GTPase activating protein 40, transcript variant X3
rho GTPase-activating protein 40 isoform X2
rho GTPase-activating protein 40 isoform X1
rho GTPase-activating protein 40 isoform X3
rho GTPase-activating protein 40 isoform X4
ARP5 actin related protein 5 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ARP5 actin related protein 5 homolog, transcript variant X2
ARP5 actin related protein 5 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ARP5 actin related protein 5 homolog, transcript variant X4
protein phosphatase 1 regulatory subunit 16B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 16B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 16B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
protein phosphatase 1 regulatory inhibitor subunit 16B isoform X1
protein phosphatase 1 regulatory inhibitor subunit 16B isoform X2
protein phosphatase 1 regulatory inhibitor subunit 16B isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
DEAH-box helicase 35, transcript variant X1
DEAH-box helicase 35, transcript variant X2
DEAH-box helicase 35, transcript variant X3
probable ATP-dependent RNA helicase DHX35 isoform X1
probable ATP-dependent RNA helicase DHX35 isoform X2
uncharacterized LOC110408423, transcript variant X9
uncharacterized LOC110408423, transcript variant X12
uncharacterized LOC110408423, transcript variant X14
uncharacterized LOC110408423, transcript variant X3
uncharacterized LOC110408423, transcript variant X8
uncharacterized LOC110408423, transcript variant X1
uncharacterized LOC110408423, transcript variant X4
uncharacterized LOC110408423, transcript variant X5
uncharacterized LOC110408423, transcript variant X11
uncharacterized LOC110408423, transcript variant X13
uncharacterized LOC110408423, transcript variant X10
uncharacterized LOC110408423, transcript variant X2
uncharacterized LOC110408423, transcript variant X7
uncharacterized LOC110408423, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized LOC110408286, transcript variant X3
uncharacterized LOC110408286, transcript variant X1
uncharacterized LOC110408286, transcript variant X2
uncharacterized LOC110408434, transcript variant X2
uncharacterized LOC110408434, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110408268, transcript variant X3
uncharacterized LOC110408268, transcript variant X1
uncharacterized LOC110408268, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
phospholipase C gamma 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
phospholipase C gamma 1, transcript variant X2
phospholipase C gamma 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
phospholipase C gamma 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
phospholipase C gamma 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X4
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X5
zinc fingers and homeoboxes 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
zinc fingers and homeoboxes 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
zinc fingers and homeoboxes 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
zinc fingers and homeoboxes 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X1
growth hormone releasing hormone, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
growth hormone releasing hormone, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
growth hormone releasing hormone, transcript variant X2
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase Src
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 78% coverage of the annotated genomic feature by RNAseq alignments
bladder cancer associated protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
bladder cancer associated protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class T
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01009259.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 111 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 43 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
recombination signal binding protein for immunoglobulin kappa J region like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
recombination signal binding protein for immunoglobulin kappa J region like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
recombining binding protein suppressor of hairless-like protein isoform X2
recombining binding protein suppressor of hairless-like protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel modifier subfamily S member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily S member 1
translocase of outer mitochondrial membrane 34
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
mitochondrial import receptor subunit TOM34
poly(A) binding protein cytoplasmic 1 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
poly(A) binding protein cytoplasmic 1 like, transcript variant X2
poly(A) binding protein cytoplasmic 1 like, transcript variant X3
polyadenylate-binding protein 1-like isoform X2
polyadenylate-binding protein 1-like isoform X1
poly(A) binding protein cytoplasmic 1 like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
polyadenylate-binding protein 1-like isoform X3
poly(A) binding protein cytoplasmic 1 like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
poly(A) binding protein cytoplasmic 1 like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
poly(A) binding protein cytoplasmic 1 like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
polyadenylate-binding protein 1-like isoform X4
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
regulating synaptic membrane exocytosis 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
regulating synaptic membrane exocytosis 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
regulating synaptic membrane exocytosis 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
regulating synaptic membrane exocytosis 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
regulating synaptic membrane exocytosis 4, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
regulating synaptic membrane exocytosis 4, transcript variant X7
regulating synaptic membrane exocytosis 4, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
regulating synaptic membrane exocytosis 4, transcript variant X11
regulating synaptic membrane exocytosis 4, transcript variant X12
regulating synaptic membrane exocytosis 4, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
regulating synaptic membrane exocytosis 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
regulating synaptic membrane exocytosis 4, transcript variant X8
regulating synaptic membrane exocytosis protein 4 isoform X3
regulating synaptic membrane exocytosis protein 4 isoform X2
regulating synaptic membrane exocytosis protein 4 isoform X1
regulating synaptic membrane exocytosis protein 4 isoform X5
regulating synaptic membrane exocytosis protein 4 isoform X6
regulating synaptic membrane exocytosis 4, transcript variant X5
regulating synaptic membrane exocytosis protein 4 isoform X4
potassium two pore domain channel subfamily K member 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
WNT1 inducible signaling pathway protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
WNT1-inducible-signaling pathway protein 2 isoform X2
WNT1 inducible signaling pathway protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
WNT1-inducible-signaling pathway protein 2 isoform X1
cAMP-dependent protein kinase inhibitor gamma, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
cAMP-dependent protein kinase inhibitor gamma, transcript variant X5
cAMP-dependent protein kinase inhibitor gamma, transcript variant X3
cAMP-dependent protein kinase inhibitor gamma, transcript variant X2
cAMP-dependent protein kinase inhibitor gamma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cAMP-dependent protein kinase inhibitor gamma isoform X1
cAMP-dependent protein kinase inhibitor gamma isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
alpha tocopherol transfer protein like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
alpha tocopherol transfer protein like, transcript variant X1
alpha tocopherol transfer protein like, transcript variant X2
alpha tocopherol transfer protein like, transcript variant X4
alpha-tocopherol transfer protein-like isoform X1
alpha-tocopherol transfer protein-like isoform X2
uncharacterized LOC110408092, transcript variant X2
uncharacterized LOC110408092, transcript variant X1
hepatocyte nuclear factor 4 alpha, transcript variant X1
hepatocyte nuclear factor 4 alpha, transcript variant X2
hepatocyte nuclear factor 4 alpha, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
hepatocyte nuclear factor 4-alpha isoform X2
hepatocyte nuclear factor 4-alpha isoform X1
hepatocyte nuclear factor 4-alpha isoform X3
R3H domain containing like, transcript variant X1
R3H domain containing like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fat storage inducing transmembrane protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
fat storage-inducing transmembrane protein 2
ganglioside induced differentiation associated protein 1 like 1
ganglioside-induced differentiation-associated protein 1-like 1
oxidative stress-responsive serine-rich protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
oxidative stress-responsive serine-rich protein 1-like, transcript variant X1
oxidative stress-responsive serine-rich protein 1-like isoform X2
oxidative stress-responsive serine-rich protein 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
oxidative stress-responsive serine-rich protein 1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
oxidative stress-responsive serine-rich protein 1-like, transcript variant X5
oxidative stress-responsive serine-rich protein 1-like, transcript variant X8
oxidative stress-responsive serine-rich protein 1-like, transcript variant X6
oxidative stress-responsive serine-rich protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
oxidative stress-responsive serine-rich protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
thyrotropin-releasing hormone receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
osteoclast stimulatory transmembrane protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
solute carrier family 2 member 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 10 isoform X1
solute carrier family 2 member 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 10 isoform X2
uncharacterized LOC110408457, transcript variant X3
uncharacterized LOC110408457, transcript variant X1
uncharacterized LOC110408457, transcript variant X4
uncharacterized LOC110408457, transcript variant X2
EYA transcriptional coactivator and phosphatase 2, transcript variant X4
EYA transcriptional coactivator and phosphatase 2, transcript variant X3
EYA transcriptional coactivator and phosphatase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
EYA transcriptional coactivator and phosphatase 2, transcript variant X2
EYA transcriptional coactivator and phosphatase 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
EYA transcriptional coactivator and phosphatase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
EYA transcriptional coactivator and phosphatase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
EYA transcriptional coactivator and phosphatase 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
EYA transcriptional coactivator and phosphatase 2, transcript variant X11
EYA transcriptional coactivator and phosphatase 2, transcript variant X8
EYA transcriptional coactivator and phosphatase 2, transcript variant X9
EYA transcriptional coactivator and phosphatase 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC110408456, transcript variant X2
uncharacterized LOC110408456, transcript variant X1
zinc finger MYND-type containing 8, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X1
zinc finger MYND-type containing 8, transcript variant X13
zinc finger MYND-type containing 8, transcript variant X18
zinc finger MYND-type containing 8, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
protein kinase C-binding protein 1 isoform X9
protein kinase C-binding protein 1 isoform X2
protein kinase C-binding protein 1 isoform X5
protein kinase C-binding protein 1 isoform X3
protein kinase C-binding protein 1 isoform X10
protein kinase C-binding protein 1 isoform X4
protein kinase C-binding protein 1 isoform X7
protein kinase C-binding protein 1 isoform X1
protein kinase C-binding protein 1 isoform X8
protein kinase C-binding protein 1 isoform X6
zinc finger MYND-type containing 8, transcript variant X21
zinc finger MYND-type containing 8, transcript variant X20
protein kinase C-binding protein 1 isoform X11
nuclear receptor coactivator 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X2
nuclear receptor coactivator 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X19
nuclear receptor coactivator 3, transcript variant X17
nuclear receptor coactivator 3, transcript variant X18
nuclear receptor coactivator 3, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X16
nuclear receptor coactivator 3, transcript variant X11
nuclear receptor coactivator 3, transcript variant X8
nuclear receptor coactivator 3, transcript variant X13
nuclear receptor coactivator 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nuclear receptor coactivator 3, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nuclear receptor coactivator 3 isoform X1
nuclear receptor coactivator 3 isoform X2
nuclear receptor coactivator 3 isoform X5
nuclear receptor coactivator 3 isoform X3
nuclear receptor coactivator 3 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
extracellular sulfatase Sulf-2 isoform X2
extracellular sulfatase Sulf-2 isoform X1
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X3
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X2
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X1
uncharacterized LOC110408062, transcript variant X1
uncharacterized LOC110408062, transcript variant X2
uncharacterized LOC110408062, transcript variant X3
ADP ribosylation factor guanine nucleotide exchange factor 2
brefeldin A-inhibited guanine nucleotide-exchange protein 2
chromosome segregation 1 like, transcript variant X1
chromosome segregation 1 like, transcript variant X2
staufen double-stranded RNA binding protein 1, transcript variant X1
staufen double-stranded RNA binding protein 1, transcript variant X3
staufen double-stranded RNA binding protein 1, transcript variant X2
staufen double-stranded RNA binding protein 1, transcript variant X4
staufen double-stranded RNA binding protein 1, transcript variant X5
staufen double-stranded RNA binding protein 1, transcript variant X6
staufen double-stranded RNA binding protein 1, transcript variant X7
double-stranded RNA-binding protein Staufen homolog 1 isoform X1
double-stranded RNA-binding protein Staufen homolog 1 isoform X3
double-stranded RNA-binding protein Staufen homolog 1 isoform X2
double-stranded RNA-binding protein Staufen homolog 1 isoform X4
double-stranded RNA-binding protein Staufen homolog 1 isoform X5
double-stranded RNA-binding protein Staufen homolog 1 isoform X6
double-stranded RNA-binding protein Staufen homolog 1 isoform X7
somatomedin-B and thrombospondin type-1 domain-containing protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
somatomedin-B and thrombospondin type-1 domain-containing protein-like, transcript variant X2
somatomedin-B and thrombospondin type-1 domain-containing protein-like, transcript variant X1
somatomedin-B and thrombospondin type-1 domain-containing protein-like
potassium voltage-gated channel subfamily B member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein-glutamine gamma-glutamyltransferase E-like
protein-glutamine gamma-glutamyltransferase 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein-glutamine gamma-glutamyltransferase 6-like, transcript variant X1
protein-glutamine gamma-glutamyltransferase 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
cyclin D1 binding protein 1, transcript variant X1
cyclin D1 binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
zinc finger NFX1-type containing 1, transcript variant X2
zinc finger NFX1-type containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
NFX1-type zinc finger-containing protein 1 isoform X1
NFX1-type zinc finger-containing protein 1 isoform X2
phosphatase and actin regulator 3, transcript variant X1
phosphatase and actin regulator 3, transcript variant X2
phosphatase and actin regulator 3 isoform X1
phosphatase and actin regulator 3 isoform X2
synaptonemal complex protein 2, transcript variant X8
synaptonemal complex protein 2, transcript variant X4
synaptonemal complex protein 2, transcript variant X3
synaptonemal complex protein 2, transcript variant X6
synaptonemal complex protein 2, transcript variant X1
synaptonemal complex protein 2, transcript variant X7
synaptonemal complex protein 2, transcript variant X2
synaptonemal complex protein 2, transcript variant X9
synaptonemal complex protein 2, transcript variant X5
synaptonemal complex protein 2 isoform X2
synaptonemal complex protein 2 isoform X1
protein phosphatase 1 regulatory subunit 3D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 217 member B, transcript variant X1
family with sequence similarity 217 member B, transcript variant X2
uncharacterized LOC110408405, transcript variant X2
uncharacterized LOC110408405, transcript variant X1
uncharacterized LOC110408405, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
TATA-box binding protein associated factor 4, transcript variant X1
transcription initiation factor TFIID subunit 4
TATA-box binding protein associated factor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
LSM family member 14B, transcript variant X3
LSM family member 14B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
LSM family member 14B, transcript variant X6
LSM family member 14B, transcript variant X2
LSM family member 14B, transcript variant X4
LSM family member 14B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
SS18L1, nBAF chromatin remodeling complex subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
SS18L1, nBAF chromatin remodeling complex subunit, transcript variant X2
calcium-responsive transactivator isoform X1
calcium-responsive transactivator isoform X2
SS18L1, nBAF chromatin remodeling complex subunit, transcript variant X3
SS18L1, nBAF chromatin remodeling complex subunit, transcript variant X4
calcium-responsive transactivator isoform X3
mitochondrial ribosome associated GTPase 2
mitochondrial ribosome-associated GTPase 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: histamine H3 receptor
oxysterol binding protein like 2, transcript variant X3
oxysterol binding protein like 2, transcript variant X1
oxysterol binding protein like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
oxysterol-binding protein-related protein 2 isoform X2
oxysterol-binding protein-related protein 2 isoform X1
adhesion regulating molecule 1, transcript variant X3
adhesion regulating molecule 1, transcript variant X2
adhesion regulating molecule 1, transcript variant X1
proteasomal ubiquitin receptor ADRM1 isoform X3
proteasomal ubiquitin receptor ADRM1 isoform X2
proteasomal ubiquitin receptor ADRM1 isoform X1
laminin subunit alpha 5, transcript variant X3
laminin subunit alpha 5, transcript variant X2
laminin subunit alpha 5, transcript variant X4
laminin subunit alpha 5, transcript variant X1
laminin subunit alpha 5, transcript variant X5
uncharacterized LOC110408010, transcript variant X2
uncharacterized LOC110408010, transcript variant X1
Cdk5 and Abl enzyme substrate 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Cdk5 and Abl enzyme substrate 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Cdk5 and Abl enzyme substrate 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Cdk5 and Abl enzyme substrate 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
CDK5 and ABL1 enzyme substrate 2 isoform X1
CDK5 and ABL1 enzyme substrate 2 isoform X2
CDK5 and ABL1 enzyme substrate 2 isoform X3
RBBP8 N-terminal like, transcript variant X2
RBBP8 N-terminal like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier organic anion transporter family member 4A1, transcript variant X2
solute carrier organic anion transporter family member 4A1, transcript variant X1
solute carrier organic anion transporter family member 4A1, transcript variant X3
solute carrier organic anion transporter family member 4A1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01026758.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 99 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 52 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
opioid growth factor receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
opioid growth factor receptor, transcript variant X2
opioid growth factor receptor isoform X1
opioid growth factor receptor isoform X2
opioid growth factor receptor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
opioid growth factor receptor isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transcription factor like 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transcription factor like 5, transcript variant X1
transcription factor-like 5 protein isoform X2
transcription factor-like 5 protein isoform X1
death inducer-obliterator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
death inducer-obliterator 1, transcript variant X3
death inducer-obliterator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
GID complex subunit 8 homolog, transcript variant X1
GID complex subunit 8 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
glucose-induced degradation protein 8 homolog
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: solute carrier family 17 member 9
basic helix-loop-helix family member e23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
class E basic helix-loop-helix protein 23
uncharacterized LOC110408418, transcript variant X1
uncharacterized LOC110408418, transcript variant X3
uncharacterized LOC110408418, transcript variant X2
YTH N6-methyladenosine RNA binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
YTH N6-methyladenosine RNA binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
YTH domain-containing family protein 1 isoform X2
YTH domain-containing family protein 1 isoform X1
baculoviral IAP repeat containing 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
baculoviral IAP repeat containing 7, transcript variant X2
baculoviral IAP repeat-containing protein 7 isoform X1
baculoviral IAP repeat-containing protein 7 isoform X2
sodium/potassium transporting ATPase interacting 4, transcript variant X8
sodium/potassium transporting ATPase interacting 4, transcript variant X7
sodium/potassium transporting ATPase interacting 4, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium/potassium transporting ATPase interacting 4, transcript variant X11
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X8
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X12
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X7
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X11
sodium/potassium transporting ATPase interacting 4, transcript variant X3
sodium/potassium transporting ATPase interacting 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X6
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X3
sodium/potassium transporting ATPase interacting 4, transcript variant X5
sodium/potassium transporting ATPase interacting 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium/potassium transporting ATPase interacting 4, transcript variant X1
sodium/potassium transporting ATPase interacting 4, transcript variant X4
sodium/potassium transporting ATPase interacting 4, transcript variant X10
sodium/potassium transporting ATPase interacting 4, transcript variant X9
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X4
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X2
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X1
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X5
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X10
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X9
ADP ribosylation factor GTPase activating protein 1, transcript variant X1
ADP ribosylation factor GTPase activating protein 1, transcript variant X3
ADP ribosylation factor GTPase activating protein 1, transcript variant X2
ADP-ribosylation factor GTPase-activating protein 1 isoform X1
ADP-ribosylation factor GTPase-activating protein 1 isoform X3
ADP-ribosylation factor GTPase-activating protein 1 isoform X2
DEP domain-containing mTOR-interacting protein-like, transcript variant X2
DEP domain-containing mTOR-interacting protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
DEP domain-containing mTOR-interacting protein-like, transcript variant X1
DEP domain-containing mTOR-interacting protein-like isoform X1
DEP domain-containing mTOR-interacting protein-like isoform X2
collagen type XX alpha 1 chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
collagen type XX alpha 1 chain, transcript variant X1
cholinergic receptor nicotinic alpha 4 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neuronal acetylcholine receptor subunit alpha-4
potassium voltage-gated channel subfamily Q member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily Q member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily KQT member 2 isoform X1
potassium voltage-gated channel subfamily KQT member 2 isoform X2
eukaryotic translation elongation factor 1 alpha 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pancreatic progenitor cell differentiation and proliferation factor
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X2
protein-L-isoaspartate O-methyltransferase domain-containing protein 2
myelin transcription factor 1, transcript variant X2
myelin transcription factor 1, transcript variant X3
myelin transcription factor 1, transcript variant X1
myelin transcription factor 1 isoform X2
myelin transcription factor 1 isoform X3
myelin transcription factor 1 isoform X1
myelin transcription factor 1, transcript variant X4
myelin transcription factor 1 isoform X4
uncharacterized LOC110408281, transcript variant X2
uncharacterized LOC110408281, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC110408425, transcript variant X2
uncharacterized LOC110408425, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110408182, transcript variant X2
uncharacterized LOC110408182, transcript variant X1
uncharacterized LOC110408182, transcript variant X3
uncharacterized LOC110408182, transcript variant X4
regulator of G protein signaling 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
regulator of G protein signaling 19, transcript variant X3
regulator of G-protein signaling 19 isoform X2
regulator of G-protein signaling 19 isoform X3
regulator of G protein signaling 19, transcript variant X1
regulator of G-protein signaling 19 isoform X1
transcription elongation factor A2, transcript variant X6
transcription elongation factor A2, transcript variant X5
transcription elongation factor A2, transcript variant X3
transcription elongation factor A2, transcript variant X2
transcription elongation factor A2, transcript variant X4
transcription elongation factor A2, transcript variant X1
transcription elongation factor A protein 2 isoform X1
transcription elongation factor A protein 2 isoform X2
sterile alpha motif domain containing 10
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sterile alpha motif domain-containing protein 10
zinc finger protein 512B, transcript variant X1
zinc finger protein 512B, transcript variant X2
uridine-cytidine kinase 1 like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uridine-cytidine kinase 1 like 1, transcript variant X2
uridine-cytidine kinase-like 1 isoform X2
uridine-cytidine kinase-like 1 isoform X1
uridine-cytidine kinase 1 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uridine-cytidine kinase-like 1 isoform X3
uncharacterized LOC110407987, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC110407987, transcript variant X3
uncharacterized LOC110407987, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member C5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member C5, transcript variant X2
DnaJ heat shock protein family (Hsp40) member C5, transcript variant X3
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
tumor protein D52 like 2, transcript variant X6
tumor protein D52 like 2, transcript variant X4
tumor protein D52 like 2, transcript variant X3
tumor protein D52 like 2, transcript variant X1
tumor protein D52 like 2, transcript variant X2
tumor protein D52 like 2, transcript variant X5
zinc finger and BTB domain containing 46, transcript variant X3
zinc finger and BTB domain containing 46, transcript variant X2
zinc finger and BTB domain containing 46, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
zinc finger and BTB domain containing 46, transcript variant X6
zinc finger and BTB domain containing 46, transcript variant X5
zinc finger and BTB domain containing 46, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
zinc finger and BTB domain containing 46, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 46 isoform X1
zinc finger and BTB domain-containing protein 46 isoform X3
zinc finger and BTB domain-containing protein 46 isoform X2
zinc finger and BTB domain-containing protein 46 isoform X4
zinc finger and BTB domain-containing protein 46 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
zinc finger CCCH-type and G-patch domain containing, transcript variant X2
zinc finger CCCH-type and G-patch domain containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
zinc finger CCCH-type with G patch domain-containing protein isoform X1
zinc finger CCCH-type with G patch domain-containing protein isoform X2
ADP ribosylation factor related protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ADP ribosylation factor related protein 1, transcript variant X1
ADP-ribosylation factor-related protein 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: tumor necrosis factor receptor superfamily member 6B
regulator of telomere elongation helicase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
regulator of telomere elongation helicase 1, transcript variant X5
regulator of telomere elongation helicase 1, transcript variant X3
regulator of telomere elongation helicase 1, transcript variant X1
regulator of telomere elongation helicase 1, transcript variant X2
regulator of telomere elongation helicase 1 isoform X2
regulator of telomere elongation helicase 1 isoform X4
regulator of telomere elongation helicase 1 isoform X3
regulator of telomere elongation helicase 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glucocorticoid modulatory element binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
glucocorticoid modulatory element binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glucocorticoid modulatory element binding protein 2, transcript variant X3
glucocorticoid modulatory element-binding protein 2 isoform X1
glucocorticoid modulatory element-binding protein 2 isoform X2
glucocorticoid modulatory element binding protein 2, transcript variant X5
glucocorticoid modulatory element binding protein 2, transcript variant X4
glucocorticoid modulatory element-binding protein 2 isoform X3
helicase with zinc finger 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
helicase with zinc finger 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
helicase with zinc finger 2, transcript variant X2
helicase with zinc finger domain 2 isoform X1
helicase with zinc finger 2, transcript variant X4
helicase with zinc finger domain 2 isoform X2
fibronectin type III domain containing 11, transcript variant X1
fibronectin type III domain containing 11, transcript variant X2
fibronectin type III domain-containing protein 11 isoform X1
fibronectin type III domain-containing protein 11 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type substrate 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type substrate 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type substrate 1-like, transcript variant X2
tyrosine-protein phosphatase non-receptor type substrate 1-like, transcript variant X4
tyrosine-protein phosphatase non-receptor type substrate 1-like isoform X1
tyrosine-protein phosphatase non-receptor type substrate 1-like isoform X2
tyrosine-protein phosphatase non-receptor type substrate 1-like, transcript variant X5
uncharacterized protein LOC110408396 isoform X4
uncharacterized protein LOC110408396 isoform X2
uncharacterized protein LOC110408396 isoform X3
uncharacterized protein LOC110408396 isoform X1
tyrosine-protein phosphatase non-receptor type substrate 1-like isoform X5
tyrosine-protein phosphatase non-receptor type substrate 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01006467.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 192 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 85 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
peptidyl-prolyl cis-trans isomerase FKBP1A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: double-strand-break repair protein rad21-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
family with sequence similarity 110 member A, transcript variant X2
family with sequence similarity 110 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
solute carrier family 52 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
solute carrier family 52 member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
solute carrier family 52 member 3, transcript variant X3
solute carrier family 52, riboflavin transporter, member 3
scratch family transcriptional repressor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
casein kinase 2 alpha 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
casein kinase 2 alpha 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
TBC1 domain family member 20, transcript variant X1
TBC1 domain family member 20, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C20orf96 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
histocompatibility minor 13, transcript variant X1
histocompatibility minor 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
minor histocompatibility antigen H13 isoform X1
minor histocompatibility antigen H13 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
bactericidal permeability-increasing protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
TPX2, microtubule nucleation factor, transcript variant X2
TPX2, microtubule nucleation factor, transcript variant X5
TPX2, microtubule nucleation factor, transcript variant X9
TPX2, microtubule nucleation factor, transcript variant X4
TPX2, microtubule nucleation factor, transcript variant X1
TPX2, microtubule nucleation factor, transcript variant X6
TPX2, microtubule nucleation factor, transcript variant X7
TPX2, microtubule nucleation factor, transcript variant X8
TPX2, microtubule nucleation factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
myosin light chain kinase 2, skeletal/cardiac muscle
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tubulin tyrosine ligase like 9, transcript variant X1
tubulin tyrosine ligase like 9, transcript variant X7
tubulin tyrosine ligase like 9, transcript variant X5
tubulin tyrosine ligase like 9, transcript variant X2
tubulin tyrosine ligase like 9, transcript variant X3
tubulin tyrosine ligase like 9, transcript variant X6
tubulin tyrosine ligase like 9, transcript variant X4
probable tubulin polyglutamylase TTLL9 isoform X1
probable tubulin polyglutamylase TTLL9 isoform X7
probable tubulin polyglutamylase TTLL9 isoform X5
probable tubulin polyglutamylase TTLL9 isoform X2
probable tubulin polyglutamylase TTLL9 isoform X3
probable tubulin polyglutamylase TTLL9 isoform X6
probable tubulin polyglutamylase TTLL9 isoform X4
tubulin tyrosine ligase like 9, transcript variant X9
dual specificity phosphatase 15, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
dual specificity phosphatase 15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
dual specificity phosphatase 15, transcript variant X3
dual specificity protein phosphatase 15 isoform X2
dual specificity protein phosphatase 15 isoform X1
dual specificity protein phosphatase 15 isoform X3
probable tubulin polyglutamylase TTLL9 isoform X9
tubulin tyrosine ligase like 9, transcript variant X8
probable tubulin polyglutamylase TTLL9 isoform X8
tubulin tyrosine ligase like 9, transcript variant X10
probable tubulin polyglutamylase TTLL9 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
CCM2 like scaffolding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
CCM2 like scaffolding protein, transcript variant X1
cerebral cavernous malformations 2 protein-like isoform X1
cerebral cavernous malformations 2 protein-like isoform X2
HCK proto-oncogene, Src family tyrosine kinase, transcript variant X3
HCK proto-oncogene, Src family tyrosine kinase, transcript variant X4
HCK proto-oncogene, Src family tyrosine kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
HCK proto-oncogene, Src family tyrosine kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
HCK proto-oncogene, Src family tyrosine kinase, transcript variant X5
transmembrane 9 superfamily member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transmembrane 9 superfamily member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
transmembrane 9 superfamily member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
transmembrane 9 superfamily member 4, transcript variant X3
transmembrane 9 superfamily member 4 isoform X1
transmembrane 9 superfamily member 4 isoform X4
transmembrane 9 superfamily member 4 isoform X2
transmembrane 9 superfamily member 4 isoform X3
PLAG1 like zinc finger 2, transcript variant X3
PLAG1 like zinc finger 2, transcript variant X1
PLAG1 like zinc finger 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
PLAG1 like zinc finger 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
GDP-fucose protein O-fucosyltransferase 1
kinesin family member 3B, transcript variant X1
kinesin family member 3B, transcript variant X3
kinesin family member 3B, transcript variant X2
additional sex combs like 1, transcriptional regulator
nucleolar protein 4 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
nucleolar protein 4 like, transcript variant X3
nucleolar protein 4 like, transcript variant X1
nucleolar protein 4 like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nucleolar protein 4 like, transcript variant X5
nucleolar protein 4 like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC110408380, transcript variant X2
uncharacterized LOC110408380, transcript variant X1
uncharacterized protein LOC110408380 isoform X1
uncharacterized protein LOC110408380 isoform X2
COMM domain containing 7, transcript variant X2
COMM domain containing 7, transcript variant X1
COMM domain-containing protein 7 isoform X2
COMM domain-containing protein 7 isoform X1
DNA methyltransferase 3 beta, transcript variant X2
DNA (cytosine-5)-methyltransferase 3B isoform X2
DNA methyltransferase 3 beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DNA methyltransferase 3 beta, transcript variant X3
DNA (cytosine-5)-methyltransferase 3B isoform X1
DNA (cytosine-5)-methyltransferase 3B isoform X3
microtubule associated protein RP/EB family member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
microtubule associated protein RP/EB family member 1, transcript variant X2
microtubule-associated protein RP/EB family member 1 isoform X1
microtubule-associated protein RP/EB family member 1 isoform X2
BPI fold-containing family B member 4-like
BPI fold containing family B member 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
BPI fold containing family B member 2, transcript variant X2
BPI fold containing family B member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
BPI fold containing family B member 2, transcript variant X1
BPI fold-containing family B member 2 isoform X2
BPI fold-containing family B member 2 isoform X1
BPI fold containing family B member 2, transcript variant X5
BPI fold containing family B member 2, transcript variant X3
BPI fold-containing family B member 2 isoform X6
BPI fold-containing family B member 2 isoform X4
BPI fold-containing family B member 2 isoform X5
BPI fold-containing family B member 2 isoform X3
BPI fold-containing family B member 6-like, transcript variant X18
BPI fold-containing family B member 6-like, transcript variant X3
BPI fold-containing family B member 6-like, transcript variant X9
BPI fold-containing family B member 6-like, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
BPI fold-containing family B member 6-like, transcript variant X17
BPI fold-containing family B member 6-like, transcript variant X20
BPI fold-containing family B member 6-like, transcript variant X2
BPI fold-containing family B member 6-like, transcript variant X5
BPI fold-containing family B member 6-like, transcript variant X7
BPI fold-containing family B member 6-like, transcript variant X4
BPI fold-containing family B member 6-like, transcript variant X10
BPI fold-containing family B member 6-like, transcript variant X14
BPI fold-containing family B member 6-like, transcript variant X12
BPI fold-containing family B member 6-like, transcript variant X6
BPI fold-containing family B member 6-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
BPI fold-containing family B member 6-like, transcript variant X8
BPI fold-containing family B member 6-like, transcript variant X11
BPI fold-containing family B member 6-like, transcript variant X15
BPI fold-containing family B member 6-like, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
BPI fold-containing family B member 6-like, transcript variant X1
BPI fold-containing family B member 6-like, transcript variant X21
BPI fold-containing family B member 6-like, transcript variant X22
BPI fold-containing family B member 6-like isoform X5
BPI fold-containing family B member 6-like isoform X6
BPI fold-containing family B member 6-like isoform X1
BPI fold-containing family B member 6-like isoform X2
BPI fold-containing family B member 6-like isoform X3
uncharacterized protein LOC110408041 isoform X4
BPI fold-containing family B member 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
BPI fold-containing family B member 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
BPI fold-containing family B member 4-like, transcript variant X3
BPI fold-containing family B member 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
BPI fold-containing family B member 4-like isoform X4
BPI fold-containing family B member 4-like isoform X2
BPI fold-containing family B member 4-like isoform X1
BPI fold-containing family B member 4-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 79% coverage of the annotated genomic feature by RNAseq alignments
CDK5 regulatory subunit associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 1, transcript variant X2
CDK5 regulatory subunit-associated protein 1 isoform X1
CDK5 regulatory subunit-associated protein 1 isoform X2
bactericidal/permeability-increasing protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
bactericidal/permeability-increasing protein, transcript variant X2
bactericidal permeability-increasing protein isoform X2
bactericidal permeability-increasing protein isoform X1
similar to RNA sequence (same species):INSD:GBYG01038355.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 57 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 57 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized protein KIAA1755 homolog
protein-glutamine gamma-glutamyltransferase 2
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X1
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X1
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X2
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X2
TELO2 interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
TELO2 interacting protein 1, transcript variant X1
TELO2 interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
V-set and transmembrane domain containing 2 like, transcript variant X2
similar to RNA sequence (same species):INSD:GBYG01013442.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 284 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
V-set and transmembrane domain containing 2 like, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 284 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 125 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
V-set and transmembrane domain-containing protein 2-like protein isoform X2
V-set and transmembrane domain-containing protein 2-like protein isoform X1
WAP four-disulfide core domain protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
WAP four-disulfide core domain protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
multiple epidermal growth factor-like domains protein 6 isoform X5
deoxynucleotidyltransferase terminal interacting protein 1
deoxynucleotidyltransferase terminal-interacting protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sorting nexin family member 21, transcript variant X1
sorting nexin family member 21, transcript variant X2
sorting nexin family member 21, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
LOW QUALITY PROTEIN: acyl-coenzyme A thioesterase 8
zinc finger SWIM-type containing 3, transcript variant X1
zinc finger SWIM domain-containing protein 3 isoform X1
zinc finger SWIM-type containing 3, transcript variant X2
zinc finger SWIM domain-containing protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger SWIM domain-containing protein 1
neuralized E3 ubiquitin protein ligase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01015840.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 221 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase RNF182-like
zinc finger protein 335, transcript variant X3
zinc finger protein 335, transcript variant X2
zinc finger protein 335, transcript variant X1
zinc finger protein 335, transcript variant X5
zinc finger protein 335, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier family 12 member 5, transcript variant X3
solute carrier family 12 member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 12 member 5 isoform X1
solute carrier family 12 member 5 isoform X3
solute carrier family 12 member 5, transcript variant X2
solute carrier family 12 member 5 isoform X2
nuclear receptor coactivator 5, transcript variant X2
nuclear receptor coactivator 5, transcript variant X1
nuclear receptor coactivator 5, transcript variant X4
nuclear receptor coactivator 5, transcript variant X3
nuclear receptor coactivator 5 isoform X1
nuclear receptor coactivator 5 isoform X2
nuclear receptor coactivator 5 isoform X3
tumor necrosis factor receptor superfamily member 5 isoform X2
tumor necrosis factor receptor superfamily member 5 isoform X3
tumor necrosis factor receptor superfamily member 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01028637.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 158 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 111 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
engulfment and cell motility 2, transcript variant X3
engulfment and cell motility 2, transcript variant X7
engulfment and cell motility 2, transcript variant X6
engulfment and cell motility 2, transcript variant X5
engulfment and cell motility 2, transcript variant X1
engulfment and cell motility 2, transcript variant X2
engulfment and cell motility 2, transcript variant X4
engulfment and cell motility protein 2 isoform X4
engulfment and cell motility protein 2 isoform X3
engulfment and cell motility protein 2 isoform X2
engulfment and cell motility protein 2 isoform X1
small nuclear ribonucleoprotein polypeptides B and B1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
small nuclear ribonucleoprotein-associated proteins B and B'
probable ATP-dependent RNA helicase DDX27
zinc finger protein 831, transcript variant X5
zinc finger protein 831, transcript variant X2
zinc finger protein 831, transcript variant X3
zinc finger protein 831, transcript variant X1
zinc finger protein 831, transcript variant X4
PRELI domain containing 3B, transcript variant X1
PRELI domain containing protein 3B isoform X1
PRELI domain containing 3B, transcript variant X2
PRELI domain containing protein 3B isoform X2
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit
ATP synthase subunit epsilon, mitochondrial
tubulin beta 1 class VI, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
tubulin beta 1 class VI, transcript variant X1
tubulin beta 1 class VI, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
negative elongation factor complex member C/D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
GNAS complex locus, transcript variant X1
GNAS complex locus, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
guanine nucleotide-binding protein G(s) subunit alpha isoform X1
guanine nucleotide-binding protein G(s) subunit alpha isoform X2
uncharacterized LOC110408291, transcript variant X4
uncharacterized LOC110408291, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC110408291, transcript variant X1
uncharacterized LOC110408291, transcript variant X3
APC down-regulated 1 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
APC down-regulated 1 like, transcript variant X2
vesicle-associated membrane protein-associated protein B/C
RAB22A, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
RAB22A, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X3
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X1
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X3
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X5
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X4
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X2
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X4
ankyrin repeat domain-containing protein 60
uncharacterized protein C20orf85 homolog
uncharacterized LOC110407994, transcript variant X1
uncharacterized LOC110407994, transcript variant X2
prostate transmembrane protein, androgen induced 1, transcript variant X3
prostate transmembrane protein, androgen induced 1, transcript variant X2
prostate transmembrane protein, androgen induced 1, transcript variant X1
uncharacterized LOC110408322, transcript variant X1
uncharacterized LOC110408322, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphoenolpyruvate carboxykinase, cytosolic [GTP]
uncharacterized LOC110408322, transcript variant X3
CCCTC-binding factor like, transcript variant X2
CCCTC-binding factor like, transcript variant X1
uncharacterized LOC110408167, transcript variant X6
uncharacterized LOC110408167, transcript variant X1
uncharacterized LOC110408167, transcript variant X3
uncharacterized LOC110408167, transcript variant X5
uncharacterized LOC110408167, transcript variant X7
uncharacterized LOC110408167, transcript variant X2
uncharacterized LOC110408167, transcript variant X4
uncharacterized LOC110408166, transcript variant X2
uncharacterized LOC110408166, transcript variant X1
uncharacterized LOC110408166, transcript variant X3
uncharacterized LOC110408166, transcript variant X5
uncharacterized LOC110408166, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ribonucleic acid export 1, transcript variant X2
ribonucleic acid export 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ribonucleic acid export 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SPO11, initiator of meiotic double stranded breaks, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SPO11, initiator of meiotic double stranded breaks, transcript variant X1
SPO11, initiator of meiotic double stranded breaks, transcript variant X3
meiotic recombination protein SPO11 isoform X2
meiotic recombination protein SPO11 isoform X1
meiotic recombination protein SPO11 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
replication termination factor 2 domain containing 1, transcript variant X2
replication termination factor 2 domain containing 1, transcript variant X1
glucosaminyl (N-acetyl) transferase family member 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
glucosaminyl (N-acetyl) transferase family member 7, transcript variant X2
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7
Cas scaffolding protein family member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Cas scaffolding protein family member 4, transcript variant X4
Cas scaffolding protein family member 4, transcript variant X1
Cas scaffolding protein family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cas scaffolding protein family member 4 isoform X3
cas scaffolding protein family member 4 isoform X4
cas scaffolding protein family member 4 isoform X2
cas scaffolding protein family member 4 isoform X1
cleavage stimulation factor subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
cleavage stimulation factor subunit 1, transcript variant X1
cleavage stimulation factor subunit 1 isoform X2
cleavage stimulation factor subunit 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
family with sequence similarity 210 member B, transcript variant X2
family with sequence similarity 210 member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC110408255, transcript variant X5
uncharacterized LOC110408255, transcript variant X4
uncharacterized LOC110408255, transcript variant X1
uncharacterized LOC110408255, transcript variant X2
uncharacterized LOC110408255, transcript variant X3
uncharacterized LOC110408252, transcript variant X2
uncharacterized LOC110408252, transcript variant X1
docking protein 5, transcript variant X1
docking protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
docking protein 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
docking protein 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X1
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, transcript variant X2
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X2
breast carcinoma amplified sequence 1, transcript variant X4
breast carcinoma amplified sequence 1, transcript variant X1
breast carcinoma amplified sequence 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
breast carcinoma amplified sequence 1, transcript variant X2
breast carcinoma amplified sequence 1, transcript variant X9
breast carcinoma amplified sequence 1, transcript variant X6
breast carcinoma amplified sequence 1, transcript variant X7
breast carcinoma amplified sequence 1, transcript variant X8
breast carcinoma amplified sequence 1, transcript variant X5
breast carcinoma-amplified sequence 1 isoform X1
breast carcinoma-amplified sequence 1 isoform X2
breast carcinoma-amplified sequence 1 isoform X5
breast carcinoma-amplified sequence 1 isoform X3
breast carcinoma-amplified sequence 1 isoform X4
zinc finger protein 217, transcript variant X1
zinc finger protein 217, transcript variant X2
zinc finger protein 217, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger protein 217, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
zinc finger protein 217, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
teashirt zinc finger homeobox 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
teashirt zinc finger homeobox 2, transcript variant X2
teashirt zinc finger homeobox 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
teashirt zinc finger homeobox 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC110408110, transcript variant X2
uncharacterized LOC110408110, transcript variant X1
ZFP64 zinc finger protein, transcript variant X2
ZFP64 zinc finger protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
spalt like transcription factor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
spalt like transcription factor 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
spalt like transcription factor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
spalt like transcription factor 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
spalt like transcription factor 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
spalt like transcription factor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
spalt like transcription factor 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
spalt like transcription factor 4, transcript variant X8
ATPase phospholipid transporting 9A (putative), transcript variant X1
ATPase phospholipid transporting 9A (putative), transcript variant X2
probable phospholipid-transporting ATPase IIA isoform X1
probable phospholipid-transporting ATPase IIA isoform X2
nuclear factor of activated T-cells 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear factor of activated T-cells 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic 2 isoform X4
nuclear factor of activated T-cells 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
nuclear factor of activated T-cells 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
nuclear factor of activated T-cells 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic 2 isoform X1
nuclear factor of activated T-cells, cytoplasmic 2 isoform X2
nuclear factor of activated T-cells, cytoplasmic 2 isoform X3
nuclear factor of activated T-cells 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
nuclear factor of activated T-cells 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear factor of activated T-cells 2, transcript variant X6
nuclear factor of activated T-cells, cytoplasmic 2 isoform X5
nuclear factor of activated T-cells, cytoplasmic 2 isoform X6
uncharacterized LOC110408404, transcript variant X2
uncharacterized LOC110408404, transcript variant X1
uncharacterized LOC110408404, transcript variant X3
uncharacterized LOC110408404, transcript variant X4
potassium voltage-gated channel modifier subfamily G member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
potassium voltage-gated channel modifier subfamily G member 1, transcript variant X2
potassium voltage-gated channel subfamily G member 1
uncharacterized LOC110408267, transcript variant X2
uncharacterized LOC110408267, transcript variant X1
adenylyltransferase and sulfurtransferase MOCS3
dolichyl-phosphate mannosyltransferase subunit 1, catalytic
dolichol-phosphate mannosyltransferase subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66% coverage of the annotated genomic feature by RNAseq alignments
activity dependent neuroprotector homeobox
similar to RNA sequence (same species):INSD:GBYG01021261.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 132 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
activity-dependent neuroprotector homeobox protein
uncharacterized LOC110408261, transcript variant X4
uncharacterized LOC110408261, transcript variant X2
uncharacterized LOC110408261, transcript variant X1
uncharacterized LOC110408261, transcript variant X7
uncharacterized LOC110408261, transcript variant X3
uncharacterized LOC110408261, transcript variant X5
uncharacterized LOC110408261, transcript variant X6
par-6 family cell polarity regulator beta
RIPOR family member 3, transcript variant X1
RIPOR family member 3, transcript variant X6
RIPOR family member 3, transcript variant X7
RIPOR family member 3, transcript variant X8
RIPOR family member 3, transcript variant X3
RIPOR family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
RIPOR family member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
RIPOR family member 3, transcript variant X4
RIPOR family member 3, transcript variant X9
RIPOR family member 3, transcript variant X11
RIPOR family member 3, transcript variant X10
protein tyrosine phosphatase, non-receptor type 1
tyrosine-protein phosphatase non-receptor type 1
uncharacterized LOC110408160, transcript variant X1
uncharacterized LOC110408160, transcript variant X2
uncharacterized LOC110408160, transcript variant X3
uncharacterized LOC110408160, transcript variant X4
uncharacterized LOC110408160, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin conjugating enzyme E2 V1, transcript variant X4
ubiquitin conjugating enzyme E2 V1, transcript variant X2
ubiquitin conjugating enzyme E2 V1, transcript variant X3
ubiquitin-conjugating enzyme E2 variant 1 isoform X2
ubiquitin-conjugating enzyme E2 variant 1 isoform X3
ubiquitin conjugating enzyme E2 V1, transcript variant X1
ubiquitin-conjugating enzyme E2 variant 1 isoform X1
ubiquitin-conjugating enzyme E2 variant 1 isoform X4
snail family transcriptional repressor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
beta-1,4-galactosyltransferase 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
beta-1,4-galactosyltransferase 5 isoform X1
spermatogenesis associated 2, transcript variant X3
spermatogenesis associated 2, transcript variant X2
spermatogenesis associated 2, transcript variant X1
spermatogenesis associated 2, transcript variant X4
spermatogenesis-associated protein 2 isoform X1
spermatogenesis-associated protein 2 isoform X2
solute carrier family 9 member A8, transcript variant X2
solute carrier family 9 member A8, transcript variant X1
solute carrier family 9 member A8, transcript variant X3
beta-1,4-galactosyltransferase 5, transcript variant X2
beta-1,4-galactosyltransferase 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
beta-1,4-galactosyltransferase 5 isoform X2
beta-1,4-galactosyltransferase 5, transcript variant X4
beta-1,4-galactosyltransferase 5 isoform X3
uncharacterized LOC110408435, transcript variant X3
uncharacterized LOC110408435, transcript variant X1
uncharacterized LOC110408435, transcript variant X2